Pemetrexed/Erlotinib as a Salvage Treatment in Patients with High EGFR-Expressing Metastatic Colorectal Cancer Following Failure of Standard Chemotherapy: A Phase II Single-Arm Prospective Study

Authors:

Abstract
Despite new agents to treat metastatic colorectal cancer (CRC), patients eventually progress and additional therapies are needed.

This publication has 30 references indexed in Scilit: